Search results
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 17 minutes agoNEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in bluebird ...
Why Bio-Path Stock Is Soaring - Bio-Path Hldgs (NASDAQ:BPTH)
Benzinga· 34 minutes agoBio-Path Holdings, Inc. BPTH shares are trading higher Thursday after the company announced the...
Bio-Rad Laboratories (BIO) to Post Q1 Earnings: What Awaits?
Zacks via Yahoo Finance· 3 hours agoThe ongoing weakness in the biopharma end markets and tightening of sanctions against Russia is...
Why Is Bio-Path (BPTH) Stock Up 89% Today?
InvestorPlace· 3 hours agoBio-Path (NASDAQ:BPTH) stock is rising higher on Thursday after the oncology company announced an update on its Phase 1/1b clinical trial of BP1002. This...
EVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTS
FOX21 Colorado Springs· 6 hours agoEvotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) and Variant Bio, Inc. today announced a collaboration agreement to identify a best-in-class ...
Equities Analysts Issue Forecasts for Gritstone bio, Inc.’s Q1 2024 Earnings (NASDAQ:GRTS)
ETF DAILY NEWS· 11 hours agoGritstone bio, Inc. (NASDAQ:GRTS – Free Report) – Equities researchers at B. Riley issued their Q1 2024 earnings estimates for Gritstone bio in a report ...
Bio-Rad (BIO) Hurt by Softness in BioPharma and Competition
Zacks via Yahoo Finance· 2 days agoBio-Rad BIO has been facing the impact of funding issues in the biopharmaceutical or BioPharma...
Bio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b...
Morningstar· 6 hours agoBio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted ...
Form Bio Establishes Scientific Advisory Board, Comprised of Renowned Experts in Cell and Gene...
Digital Journal· 5 hours agoVector Engineering, Viral Vector Delivery Systems and Next-Generation Gene Transfer Technologies Further Cements Form Bio's Position as a Leader in AI-Driven Cell and Gene ...
Tourmaline Bio, Inc. (NASDAQ:TRML) Given Average Recommendation of “Buy” by Analysts
ETF DAILY NEWS· 15 hours agoTourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) has earned an average recommendation of “Buy” from the six ratings firms that are currently covering the firm, MarketBeat.com ...
